EUVIMEDEUVIMED entdecken
Crossref

TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of MCL‐1

Ying Cai iD, Yun Li iD, Yingjie Xu iD, Wen Yang iD, Masha Huang iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202400249rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Ying Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong Univer…. Hauptthemen laut MEDLINE: Myeloid Cell Leukemia Sequence 1 Protein, Ovarian Neoplasms, Ubiquitination, Apoptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Ministry of Science and Technology (MOST), National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum resistance remains a major contributor to the poor prognosis of ovarian cancer. Anti‐apoptotic protein myeloid cell leukemia‐1 (MCL‐1) has emerged as a promising target for overcoming drug resistance, but different cancer cells utilize distinct protein degradation pathways to alter MCL‐1 level. We systematically investigated E3 ligases to identify novel candidates that mediate platinum resistance in ovarian cancer. Transcription Elongation Factor B (TCEB3) has been identified as a novel E3 ligase recognition subunit that targets MCL‐1 in the cytoplasm during platinum treatment other than its traditional function of targeting the Pol II in the nuclear compartment. TCEB3 expression is downregulated in platinum‐resistant cell lines and this low expression is associated with poor prognosis. The ubiquitination of MCL‐1 induced by TCEB3 leads to cell death in ovarian cancer. Moreover, platinum treatment increased the cytoplasm proportion of TCEB3, and the cytoplasm localization of TCEB3 is important for its targeting of MCL‐1. This study emphasizes the dual function of TCEB3 in homeostasis maintenance and in cell fate determination under different conditions, and provides a new insight into drug resistance in ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid Cell Leukemia Sequence 1 ProteinOvarian NeoplasmsUbiquitinationApoptosisDrug Resistance, NeoplasmHumansFemaleCell Line, TumorUbiquitin-Protein LigasesProteolysisTranscriptional Elongation FactorsAnimalsMice

Stichwörter der Autor:innen

MCL‐1TCEB3platinum resistanceubiquitination

Substanzen

Myeloid Cell Leukemia Sequence 1 ProteinMCL1 protein, humanUbiquitin-Protein LigasesTranscriptional Elongation Factors

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Department of Neonatology, The Affiliated Children's Hospital of Jiangnan University, Wuxi, P. R. China.

ORCID-Profile: Ying Cai, Yun Li, Yingjie Xu, Wen Yang, Masha Huang

Förderung

  • Ministry of Science and Technology (MOST)
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Cai, Y., Li, Y., Xu, Y., Yang, W., & Huang, M. (2024). TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of MCL‐1. The FASEB Journal. https://doi.org/10.1096/fj.202400249rr

Vancouver

Cai Y, Li Y, Xu Y, Yang W, Huang M. TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of MCL‐1. The FASEB Journal. 2024. doi:10.1096/fj.202400249rr

BibTeX
@article{Cai2024,
  author = {Cai, Ying and Li, Yun and Xu, Yingjie and Yang, Wen and Huang, Masha},
  title = {TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of MCL‐1},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202400249rr}
}
Kostenlos starten →